Evidence map›Paper›PMID 25742460›Full record

ArticleACS synthetic biology2015

A tetO Toolkit To Alter Expression of Genes in Saccharomyces cerevisiae.

Josh T Cuperus, Russell S Lo, Lucia Shumaker, Julia Proctor, Stanley Fields

Abstract read
In one paragraph

Article in ACS synthetic biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. A Toolkit for Precise, Multigene Control inACS synthetic biology · 2022
    Article
  4. Article
  5. Review
  6. Biology · 2021
    Review
  7. Article
  8. Preferences in a trait decision determined by transcription factor variants.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Josh T Cuperus†Howard Hughes Medical Institute, ‡Department of Genome Sciences, §Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
Russell S Lo†Howard Hughes Medical Institute, ‡Department of Genome Sciences, §Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
Lucia Shumaker†Howard Hughes Medical Institute, ‡Department of Genome Sciences, §Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
Julia Proctor†Howard Hughes Medical Institute, ‡Department of Genome Sciences, §Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
Stanley Fields†Howard Hughes Medical Institute, ‡Department of Genome Sciences, §Department of Medicine, University of Washington, Seattle, Washington 98195, United States.
University of Washington · USHoward Hughes Medical Institute · US

Funding

TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Howard Hughes Medical InstituteNIGMS NIH HHS P41 GM103533
6 · The paper itself

Abstract

Strategies to optimize a metabolic pathway often involve building a large collection of strains, each containing different versions of sequences that regulate the expression of pathway genes. Here, we develop reagents and methods to carry out this process at high efficiency in the yeast Saccharomyces cerevisiae. We identify variants of the Escherichia coli tet operator (tetO) sequence that bind a TetR-VP16 activator with differential affinity and therefore result in different TetR-VP16 activator-driven expression. By recombining these variants upstream of the genes of a pathway, we generate unique combinations of expression levels. Here, we built a tetO toolkit, which includes the I-OnuI homing endonuclease to create double-strand breaks, which increases homologous recombination by 10(5); a plasmid carrying six variant tetO sequences flanked by I-OnuI sites, uncoupling transformation and recombination steps; an S. cerevisiae-optimized TetR-VP16 activator; and a vector to integrate constructs into the yeast genome. We introduce into the S. cerevisiae genome the three crt genes from Erwinia herbicola required for yeast to synthesize lycopene and carry out the recombination process to produce a population of cells with permutations of tetO variants regulating the three genes. We identify 0.7% of this population as making detectable lycopene, of which the vast majority have undergone recombination at all three crt genes. We estimate a rate of ∼20% recombination per targeted site, much higher than that obtained in other studies. Application of this toolkit to medically or industrially important end products could reduce the time and labor required to optimize the expression of a set of metabolic genes.

Indexed as

Bacterial ProteinsCarotenoidsCarrier ProteinsErwiniaEscherichia coliGenetic VectorsHomologous RecombinationLycopeneMetabolic EngineeringSaccharomyces cerevisiaeBacterial ProteinsCarotenoidsCarrier ProteinsLycopeneTet O resistance protein, Bacteriagenome engineeringhomologous recombinationlycopenemetabolic engineeringtetO elementyeast

Identifiers

PMID25742460
PMCPMC4506738
OpenAlexW2054578033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.